|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Amy Finkelstein , Kenneth Arrow , Jonathan Gruber , Joseph NewhousePublisher: Columbia University Press Imprint: Columbia University Press Dimensions: Width: 14.00cm , Height: 2.00cm , Length: 21.00cm Weight: 0.298kg ISBN: 9780231163804ISBN 10: 0231163800 Pages: 160 Publication Date: 02 December 2014 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Language: English Table of ContentsForeword, by Joseph E. Stiglitz Introduction, by Joseph P. Newhouse Moral Hazard in Health Insurance: Developments Since Arrow (1963), by Amy Finkelstein Commentary, by Jonathan Gruber Commentary, by Kenneth J. Arrow Commentary, by Joseph E. Stiglitz Discussion Arrow (1963): Uncertainty and the Welfare Economics of Medical Care, by Kenneth J. Arrow Notes on Contributors IndexReviewsAny course in health economics will benefit from Amy Finkelstein's concise and accessible synthesis of the literature on moral hazard (a.k.a. demand response). I recommend it highly. -- Randall P. Ellis, Boston University The relationship between health insurance and medical care, termed moral hazard, is one of the most fundamental in health economics. This volume focuses on that relationship, and with her crisp, clear writing, Amy Finkelstein makes state-of-the-art research in health economics accessible to readers with limited technical backgrounds--while also providing the intuition that underlies this research and that often escapes the technically sophisticated. I can only say Bravo! for the superb contribution made by this book. -- Michael Grossman, City University of New York and National Bureau of Economic Research This thorough and lucid work by Amy Finkelstein should convince anyone of the existence and importance of moral hazard in health insurance. Patient cost sharing powerfully affects not only the use, quality, and price of care for consumers at all income levels, but also the costs and premiums of public and private insurances. She also clearly outlines the challenge in harnessing the power of cost sharing to discourage beneficial care that is not worth its cost, so that medical spending is controlled but care of high value is sustained. -- Mark V. Pauly, University of Pennsylvania Any course in health economics will benefit from Amy Finkelstein's concise and accessible synthesis of the literature on moral hazard (a.k.a. demand response). I recommend it highly! -- Randall P. Ellis, Boston University Any course in health economics will benefit from Amy Finkelstein's concise and accessible synthesis of the literature on moral hazard (a.k.a. demand response). I recommend it highly. -- Randall P. Ellis, Boston University The relationship between health insurance and medical care, termed moral hazard, is one of the most fundamental in health economics. This volume focuses on that relationship, and with her crisp, clear writing, Amy Finkelstein makes state-of-the-art research in health economics accessible to readers with limited technical backgrounds-while also providing the intuition that underlies this research and that often escapes the technically sophisticated. I can only say Bravo! for the superb contribution made by this book. -- Michael Grossman, City University of New York and National Bureau of Economic Research This thorough and lucid work by Amy Finkelstein should convince anyone of the existence and importance of moral hazard in health insurance. Patient cost sharing powerfully affects not only the use, quality, and price of care for consumers at all income levels, but also the costs and premiums of public and private insurances. She also clearly outlines the challenge in harnessing the power of cost sharing to discourage beneficial care that is not worth its cost, so that medical spending is controlled but care of high value is sustained. -- Mark V. Pauly, University of Pennsylvania [Moral Hazard in Health Insurance] reads like a fireside chat among a group of distinguished, articulate health economists. * Choice * Any course in health economics will benefit from Amy Finkelstein's concise and accessible synthesis of the literature on moral hazard (a.k.a. demand response). I recommend it highly! -- Randall P. Ellis, Boston University The relationship between health insurance and medical care, termed moral hazard, is one of the most fundamental in health economics. This volume focuses on that relationship, and with her crisp, clear writing, Amy Finkelstein makes state-of-the-art research in health economics accessible to readers with limited technical backgrounds--while also providing the intuition that underlies this research and that often escapes the technically sophisticated. I can only say bravo for the superb contribution made by this book! -- Michael Grossman, City University of New York and National Bureau of Economic Research Any course in health economics will benefit from Amy Finkelstein's concise and accessible synthesis of the literature on moral hazard (a.k.a. demand response). I recommend it highly! -- Randall P. Ellis, Boston University The relationship between health insurance and medical care, termed moral hazard, is one of the most fundamental in health economics. This volume focuses on that relationship, and with her crisp, clear writing, Amy Finkelstein makes state-of-the-art research in health economics accessible to readers with limited technical backgrounds--while also providing the intuition that underlies this research and that often escapes the technically sophisticated. I can only say bravo for the superb contribution made by this book! -- Michael Grossman, City University of New York and National Bureau of Economic Research This thorough and lucid work by Amy Finkelstein should convince anyone of the existence and importance of moral hazard in health insurance. Patient cost sharing does powerfully affect the use, quality, and price of care for consumers at all income levels, and affects the costs and premiums of public and private insurances as well. She also clearly outlines the challenge in harnessing the power of cost sharing to discourage beneficial care that is not worth its cost, so that medical spending is controlled but care of high value sustained. -- Mark V. Pauly, University of Pennsylvania Author InformationAmy Finkelstein is the Ford Professor of Economics at the Massachusetts Institute of Technology, codirector of JPAL North America, and codirector of the Public Economics Program at the National Bureau of Economic Research. She is a recipient of the John Bates Clark medal from the American Economic Association, the ASHEcon Medal from the American Society of Health Economics, and the Elaine Bennett Research Prize, awarded by the Committee on the Status of Women in the Economics Profession. Tab Content 6Author Website:Countries AvailableAll regions |